Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) May Be an Alternative Preventive Therapy in Children with Cerebral Palsy
Date
2015Author
YILMAZ, Esra Yamac
Tuna, Elif Bahar
Aytepe, Zeynep
Ozdas, Didem Oner
Metadata
Show full item recordAbstract
Purpose: To evaluate the effect of casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) on the buffering capacity of saliva and plaque pH in individuals with cerebral palsy (CP).
Collections
- Makale [92796]